Evidence map›Paper›PMID 34013281›Full record

ArticlemedRxiv : the preprint server for health sciences2021

Antibody Response to COVID-19 vaccination in Patients Receiving Dialysis.

Shuchi Anand, Maria E Montez-Rath, Jialin Han, Pablo Garcia, LinaCel Cadden, Patti Hunsader, Russell Kerschmann, Paul Beyer, Mary Dittrich, Geoffrey A Block and 3 more

Abstract readPreprint
In one paragraph

Article in medRxiv : the preprint server for health sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors.

Shuchi AnandDepartment of Medicine (Nephrology), Stanford University.
Maria E Montez-RathDepartment of Medicine (Nephrology), Stanford University.
Jialin HanDepartment of Medicine (Nephrology), Stanford University.
Pablo GarciaDepartment of Medicine (Nephrology), Stanford University.
LinaCel CaddenAscend Clinical Laboratory.
Patti HunsaderAscend Clinical Laboratory.
Russell KerschmannAscend Clinical Laboratory.
Paul BeyerAscend Clinical Laboratory.
Mary DittrichUS Renal Care.
Geoffrey A BlockUS Renal Care.
Scott D BoydDepartment of Pathology, Stanford University.
Julie ParsonnetDepartments of Medicine (Infectious Diseases and Geographic Medicine), and Epidemiology and Population Health, Stanford University.
Glenn M ChertowDepartments of Medicine (Nephrology), and Epidemiology and Population Health, Stanford University.

Funding

Chronic kidney disease of unknown etiology: applying a multidisciplinary approach to investigate the world's most common tubulointerstitial kidney diseaseR01DK127138 · NIDDK · STANFORD UNIVERSITY · PI MONTEZ RATH, MARIA · 2021 to 2025
$2.7M
Mentoring Patient-Oriented Clinical Investigators in NephrologyK24DK085446 · NIDDK · STANFORD UNIVERSITY · PI CHERTOW, GLENN MATTHEW · 2010 to 2022
$1.4M
NIDDK NIH HHS K24 DK085446NIDDK NIH HHS R01 DK127138
6 · The paper itself

Abstract

Background: Patients receiving dialysis may mount impaired responses to COVID19 vaccination. Methods: We report antibody response to vaccination from 1140 patients without, and 493 patients with pre-vaccination SARS-CoV-2 RBD antibody. We used commercially available assays (Siemens) to test remainder plasma monthly in association with vaccination date and type, and assess prevalence of absent total receptor binding antibody, and absent or attenuated (index value < 10) semiquantitative receptor binding domain IgG index values. We used Poisson regression to evaluate risk factors for absent or attenuated response to vaccination. Results: Among patients who were seronegative versus seropositive before vaccination, 62% and 56% were ≥65 years old, 20% and 24% were Hispanic, and 22% and 23% were Black. Median IgG index values rose steadily over time, and were higher among the seropositive than in the seronegative patients after completing vaccination (150 [25 Conclusions: More than one in five patients receiving dialysis had evidence of an attenuated immune response to COVID19 vaccination.

Indexed as

COVID-19immune responseSARS-CoV-2vaccinationvulnerable populations

Identifiers

PMID34013281
PMCPMC8132255

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.